Standardized cannabis in multiple sclerosis: a case report
Abstract A 52 year old female suffering from severe progressive multiple sclerosis was administered quantifiable amounts of standardized cannabis and monitored over the period of one year, while providing daily pain charts and records of her condition. An average daily intake of 500 mg of Tetrahydrocannabinol as cannabis was required to achieve a desired quality of life. Authors: Paul Hornby, Manju Sharma Affiliations: Department of Medical Cannabis Research, The Green Cross Society of BC, 2127, Kingsway, Vancouver, B.C., V5N 2T4,
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in